Bosh sahifaPRQR • NASDAQ
add
ProQR Therapeutics NV
Yopilish kursi
2,42 $
Kunlik diapazon
2,18 $ - 2,46 $
Yillik diapazon
1,61 $ - 4,62 $
Bozor kapitalizatsiyasi
240,40 mln USD
Oʻrtacha hajm
500,81 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 3,98 mln | 190,58% |
Joriy xarajat | 12,70 mln | 44,93% |
Sof foyda | -8,11 mln | -42,00% |
Sof foyda marjasi | -203,67 | 51,13% |
Har bir ulushga tushum | -0,08 | 0,41% |
EBITDA | -8,03 mln | -18,95% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 89,40 mln | -25,84% |
Jami aktivlari | 106,85 mln | -24,77% |
Jami passivlari | 81,87 mln | -14,45% |
Umumiy kapital | 24,98 mln | — |
Tarqatilgan aksiyalar | 81,68 mln | — |
Narxi/balansdagi bahosi | 7,81 | — |
Aktivlardan daromad | -19,38% | — |
Kapitaldan daromad | -46,15% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -8,11 mln | -42,00% |
Operatsiyalardan naqd pul | -5,66 mln | 24,65% |
Sarmoyadan naqd pul | 16,71 mln | 5 030,38% |
Moliyadan naqd pul | -453,00 ming | -61,21% |
Naqd pulning sof oʻzgarishi | 10,43 mln | 230,22% |
Boʻsh pul | 743,50 ming | 156,44% |
Haqida
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
Tashkil etilgan
2012
Sayt
Xodimlar soni
157
